精品国产一区二区桃色

Journal News

From the Journals: 精品国产一区二区桃色

Indumathi Sridharan
Aug. 30, 2024

A deep learning approach to phosphoproteomics. Untangling complex proteomics mass spec data. Read about papers on these topics recently published in the journal Molecular & Cellular Proteomics.

 

A deep learning approach to phosphoproteomics

An example of a phosphorylated protein; X-ray structure of an active ERK2 kinase. The phosphorylated threonine and tyrosine residues are highlighted in red.
Bubus, CC BY-SA 3.0 / Wikimedia Commons
An example of a phosphorylated protein; X-ray structure of an active ERK2 kinase. The phosphorylated threonine and tyrosine residues are highlighted in red.

The post-translational modification known as phosphorylation regulates numerous cellular functions, including cell growth, movement and metabolism. Phosphoproteomics, the study of phosphorylated proteins, offers valuable insights into dynamic changes in signaling pathways mediated by phosphorylation. Phosphoproteomics relies on mass spectrometry and computational methods to detect phosphorylated sites within a protein sequence. However, accurate detection is challenging due to the transient nature and low abundance of phosphorylated peptides relative to the proteome. Moreover, different computational methods yield varying outcomes, thus undermining confidence in the results.

In a recent published in Molecular & Cellular Proteomics, Xinpei Yi and colleagues from Baylor College of Medicine and the Liver Cancer Institute at Fudan University employed deep learning to enhance phosphoproteomics accuracy. Deep learning is an artificial intelligence method that discerns patterns from vast amounts of unstructured data using neural networks.

Yi and collaborators used a multifaceted approach that included deep-learning algorithms for predicting peptide retention time and fragment ion intensity, a statistical scoring algorithm that integrates these deep-learning predictions for determining the probability of a site being phosphorylated, and a machine learning algorithm that also integrates the deep learning predictions for identifying peptides based on theoretical spectra. Compared to standalone algorithms, this integrative approach, named DeepRescore2, identified more phosphorylated peptides in synthetic and biological data sets from normal and liver cancer tissues.  

Accurately identifying phosphopeptides can aid in precise inference of the activity of kinases, which drive phosphorylation. The authors used DeepRescore2 to infer activity of epidermal growth factor receptor kinase, a biomarker of liver cancer. DeepRescore2 correctly inferred high kinase activity in liver cancer samples from patients with poor prognoses. The combinatorial deep learning approach used in the study enables accurate profiling of phosphoproteins and may serve as a prognostic tool. Combining DeepRescore2 with other algorithms enables more precise detection of phosphorylation activity, thus paving the way for biomarker-guided cancer therapies.

Untangling complex proteomics mass spec data

Data-independent acquisition, or DIA, is a popular technique used to analyze proteomes by mass spectrometry, or MS. In DIA, all detectable ions from a proteomics sample are iteratively analyzed, much like observing a crowded street one angle at a time. Despite the broad coverage and sensitivity DIA provides, its application is limited due to the difficulty in discerning similar molecules with overlapping signals in a complex sample.

In a recent  published in the journal Molecular & Cellular Proteomics, Sophia Steigerwald at the Max Planck Institute of Biochemistry and colleagues combined DIA with an advanced signal processing method, the phase–constrained spectrum deconvolution method, or ΦSDM, to tackle the challenge of complex spectra. The ΦSDM method imposes mathematical constraints based on the phase information of peptide ions to untangle overlapping signals within a mass spectrum. The authors tested the ΦSDM–DIA approach using HeLa cells.

By implementing ΦSDM signal processing on additional graphics processing units, the researchers quickly achieved a higher signal-to-noise ratio and 15% more peptide coverage compared to conventional methods, particularly in samples with short gradient times. Thus, advanced analytical techniques such as ΦSDM–DIA may help unravel unknown cellular pathways and events driven by complex proteomes or transient proteins without compromising on speed, quality and accuracy.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Indumathi Sridharan

Indumathi (Indu) Sridharan holds a Ph.D. in molecular biochemistry and currently works as a product lead at Medidata AI. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Omega-3 fats linked to healthy aging and improved heart metabolism
Journal News

Omega-3 fats linked to healthy aging and improved heart metabolism

Aug. 1, 2025

Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.